Mechanical Ventilation during ECMO: Lessons from Clinical Trials and Future Prospects

Fior, G., Colon, Z., Peek, G. J., & Fraser, J. F. Semin Respir Crit Care Med DOI: 10.1055/s-0042-1749450

Absract: Acute Respiratory Distress Syndrome (ARDS) accounts for 10% of ICU admissions and affects 3 million patients each year. Despite decades of research, it is still associated with one of the highest mortality rates in the critically ill. Advances in supportive care, innovations in technologies and insights from recent clinical trials have contributed to improved outcomes and a renewed interest in the scope and use of Extracorporeal life support (ECLS) as a treatment for severe ARDS, including high flow veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) and low flow Extracorporeal Carbon Dioxide Removal (ECCO2R).